Brinker Capital Investments’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-14,471
| Closed | -$2.11M | – | 1423 |
|
|
2022
Q2 | $2.11M | Buy |
14,471
+3,038
| +27% | +$443K | 0.04% | 458 |
|
|
2022
Q1 | $1.36M | Sell |
11,433
-1,319
| -10% | -$156K | 0.02% | 679 |
|
|
2021
Q4 | $1.76M | Buy |
12,752
+8,780
| +221% | +$1.21M | 0.03% | 620 |
|
|
2021
Q3 | $386K | Hold |
3,972
| – | – | 0.01% | 1058 |
|
|
2021
Q2 | $386K | Buy |
3,972
+58
| +1% | +$5.64K | 0.01% | 1111 |
|
|
2021
Q1 | $268K | Sell |
3,914
-668
| -15% | -$45.7K | ﹤0.01% | 1083 |
|
|
2020
Q4 | $393K | Buy |
+4,582
| New | +$393K | 0.01% | 884 |
|